The new diterpene isodojaponin D inhibited LPS-induced microglial activation through NF-kappaB and MAPK signaling pathways
- Authors
- Lim, Ji-Youn; Won, Tae Joon; Hwang, Bang Yeon; Kim, Hak Rim; Hwang, Kwang Woo; Sul, Donggeun; Park, So-Young
- Issue Date
- 10-9월-2010
- Publisher
- ELSEVIER SCIENCE BV
- Keywords
- Isodojaponin D (19-hydroxy-1,6-diacetoxy-6,7-seco-ent-kaur-16-en-15-one-7,20-olide); COX-2; iNOS; Cytokines; NF-kappa B; MAPKs; Lipopolysaccharide; BV2 cells
- Citation
- EUROPEAN JOURNAL OF PHARMACOLOGY, v.642, no.1-3, pp.10 - 18
- Indexed
- SCIE
SCOPUS
- Journal Title
- EUROPEAN JOURNAL OF PHARMACOLOGY
- Volume
- 642
- Number
- 1-3
- Start Page
- 10
- End Page
- 18
- URI
- https://scholar.korea.ac.kr/handle/2021.sw.korea/115687
- DOI
- 10.1016/j.ejphar.2010.05.047
- ISSN
- 0014-2999
- Abstract
- Neuroinflammation with prolonged microglial activation leads to increased levels of pro-inflammatory mediators and subsequently contributes to neuronal dysfunction and neuronal loss. Therefore, pharmacological suppression of neuroinflammation would theoretically slow the progression of neurodegenerative disease. In this study, we investigated the anti-inflammatory effects and possible mechanisms of isodojaponin D (19-hydroxy-1 alpha,6-diacetoxy-6,7-seco-ent-kaur-16-en-15-one-7,20-olide), a new diterpene isolated from Isodon japonicus against lipopolysaccharide(LPS)-induced microglial activation in BV2 cells. Results from RT-PCR and Western blot showed that pretreatment with isodojaponin D (5 and 10 mu g/ml) prior to treatment with LPS (1 mu g/ml) significantly decreased U'S-induced production of cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) in a dose-dependent manner. In addition, LPS-induced pro-inflammatory cytokines, including IL-1 beta, IL-6, and TNF-alpha, were also decreased by pretreatment with isodojaponin D. This effect was accompanied by a decrease in translocations of Nuclear Factor-KappaB (NF-kappa B) p50 and p65 from the cytoplasm to the nucleus and by a decrease in 1 kappaB (I kappa B) degradation. In addition, pretreatment with isodojaponin D significantly attenuated LPS-induced mitogen-activated protein kinase (MAPK) activation. Taken together, these results suggest that isodojaponin D suppressed LPS-induced microglial activation and production of pro-inflammatory mediators by inhibition of the NF-kappa B signaling pathway and phosphorylation of MAPKs. These results suggest that isodojaponin D could play a beneficial role in treatment of neurodegenerative disease. C 2010 Elsevier BM. All rights reserved.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Graduate School > Department of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.